Biotech RadarJobs updated

COMPANY

Prime Medicine

HQ: Cambridge, MA source · primemedicine.com ↗

Clinical Phase 2

9 open jobs · last seen Oct 23, 2026 · 6 sources

Keywords: Wilson disease Chronic Granulomatous Disease Wilson's Disease PM577a PM359

Location: Cambridge, MA · source · Oct 14, 2026

Profile checked Oct 10, 2026

Since the raise (Aug 1, 2025): 9 of 9 open jobs were first seen after it.

9Open jobs$168.2MRaised (2 yrs)3Trials (company is sponsor)

Hiring

TitleLocation (from posting)Employer postedFirst seen
Senior Manager, Regulatory OperationsCambridge, MAOct 7, 2026Oct 9, 2026
Associate Scientist/Engineer II Technology, Development and Operations - ChemistryCambridge, MAOct 7, 2026Oct 9, 2026
Research Associate, Automation & AssaysCambridge, MAOct 7, 2026Oct 9, 2026
VP, Regulatory AffairsCambridge, MAOct 2, 2026Oct 9, 2026
Laboratory Operations SpecialistCambridge, MASep 18, 2026Oct 9, 2026

See all 9 jobs

Timeline

  1. Board tracked Radar started tracking this company’s job board (9 open jobs at last check). source ↗
  2. Trial start Phase 1/Phase 2: A Study of the Safety and Efficacy of Prime Editing (PM577) in Participants With Wilson Disease (WD) source ↗
  3. Trial start —: Prescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical Trial source ↗
  4. Raise Follow-on offering: $144.2M (total, as published), announced Aug 1, 2025. Source: company release on GlobeNewswire. source ↗
  5. Raise Private placement: $24M (up to, as announced), announced Jul 16, 2025. Source: company release on GlobeNewswire. source ↗
  6. Trial start Phase 1/Phase 2: A Study of the Safety and Efficacy of Prime Editing (PM359) in Participants With p47phox Autosomal Recessive Chronic Granulomatous Disease (CGD ) source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Open jobs 9

TitleLocation (from posting, not HQ)Employer postedFirst seenLevel
Senior Manager, Regulatory OperationsCambridge, MAOct 7, 2026Oct 9, 2026Senior
Associate Scientist/Engineer II Technology, Development and Operations - ChemistryCambridge, MAOct 7, 2026Oct 9, 2026Mid
Research Associate, Automation & AssaysCambridge, MAOct 7, 2026Oct 9, 2026Mid
VP, Regulatory AffairsCambridge, MAOct 2, 2026Oct 9, 2026Executive
Laboratory Operations SpecialistCambridge, MASep 18, 2026Oct 9, 2026Mid
Medical Director, Clinical DevelopmentCambridge, MASep 10, 2026Oct 9, 2026Senior
Senior Quality Engineering SpecialistCambridge, MASep 7, 2026Oct 9, 2026Senior
Senior Scientist / Senior Engineer, LNP Process DevelopmentCambridge, MAJul 17, 2026Oct 9, 2026Mid
Senior Director, BiometricsCambridge, MAJul 8, 2026Oct 9, 2026Senior

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.

Funding

Raised: $168.2M. Last 2 years.

Clinical trials (lead sponsor) 3

RecordTitlePhaseStatusStartPrimary completion
NCT07748403A Study of the Safety and Efficacy of Prime Editing (PM577) in Participants With Wilson Disease (WD)Phase 1/Phase 2Recruiting2026-092028-11 (estimated)
NCT07226622Prescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical TrialNot listedActive, not recruitingDec 29, 20252027-12 (estimated)
NCT06559176A Study of the Safety and Efficacy of Prime Editing (PM359) in Participants With p47phox Autosomal Recessive Chronic Granulomatous Disease (CGD )Phase 1/Phase 2Enrolling by invitationOct 17, 20242030-01 (estimated)

Connect

See your connections at Prime Medicine on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-18

Feedback